Evidence map›Paper›PMID 42716956›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Effects of sodium reduction interventions on home and morning home blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Atsushi Sakima, Hisatomi Arima, Kimika Arakawa, Daigoro Hirohama, Kento Kitada, Einosuke Mizuta, Sayaka Nagata, Hiroki Nakano, Sayoko Ogura, Kensuke Sasaki and 19 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Atsushi SakimaHealth Administration Center, University of the Ryukyus, Okinawa, Japan. asakima@cs.u-ryukyu.ac.jp.
Hisatomi ArimaDepartment of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Kimika ArakawaDepartment of Clinical Laboratory, NHO Kyushu Medical Center, Fukuoka, Japan.
Daigoro HirohamaDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Kento KitadaDepartment of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Einosuke MizutaDepartment of Cardiology, Sanin Rosai Hospital, Tottori, Japan.
Sayaka NagataDepartment of Food Science and Technology, Faculty of Health and Nutrition, Minami Kyusyu University, Miyazaki, Japan.
Hiroki NakanoDepartment of Cardiology, Tokyo Medical University, Tokyo, Japan.
Sayoko OguraDivision of Laboratory Medicine, Department of Pathology and Microbiology, School of Medicine, Nihon University, Tokyo, Japan.
Kensuke SasakiDepartment of Nephrology, Hiroshima University Hospital, Hiroshima, Japan.
Jun SuzukiDepartment of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.
Hiroyuki TakaseDepartment of Internal Medicine, Enshu Hospital, Hamamatsu, Shizuoka, Japan.
Kohei UedaDepartment of Physiology, School of Medicine, International University of Health and Welfare, Narita, Chiba, Japan.
Makiko AbeDepartment of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Takashi HisamatsuCenter for Stroke and Cardiovascular Disease Informatics, National Cerebral and Cardiovascular Center, Suita, Japan.
Yukari TakemiFaculty of Nutrition, Japan Nutrition University, Sakado, Japan.
Nobuhito HirawaDepartment of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Chisa MatsumotoDepartment of Cardiology, Tokyo Medical University, Tokyo, Japan.
Shin-Ichiro MiuraDepartment of Cardiology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Masaki MogiDepartment of Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
Akira NishiyamaDepartment of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Akihiro NomuraDivision of Convergence Science, Kanazawa University Graduate School of Frontier Science Initiative, Kanazawa, Japan.
Takayoshi OhkuboDepartment of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
Yusuke OhyaOkinawa Hokubu Medical Foundation, Nago, Okinawa, Japan.
Shigeru ShibataDivision of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yasuharu TabaraGraduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Koichi YamamotoDepartment of Geriatric and General Medicine, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Katsuyuki MiuraNCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive sodium chloride (salt) intake significantly contributes to hypertension and cardiovascular diseases, and reducing sodium is a cornerstone of non-pharmacological management of hypertension. Although the antihypertensive effects of sodium reduction are well established, most existing evidence is from office blood pressure (BP) measurements, with limited data available on home BP. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effects of sodium reduction on home BP. We searched PubMed and the Cochrane Library from inception to September 2025 and included 23 RCTs comprising 4110 participants. Sodium reduction significantly reduced home systolic BP (SBP) (mean difference [MD], -3.66 mmHg; 95% confidence interval [CI], -4.86 to -2.45; P < 0.001) and home diastolic BP (MD, -1.40 mmHg; 95% CI, -2.08 to -0.71; P < 0.001). Nine studies that reported morning home BP also showed reduced morning home SBP (MD, -4.06 mmHg; 95% CI, -6.60 to -1.52; P = 0.002). Greater reductions in home SBP were observed in predominantly hypertensive populations than in non-hypertensive populations (P for heterogeneity = 0.003). No significant differences were detected across other predefined subgroups. Sodium reduction interventions were also associated with significant reductions in salt intake, urinary sodium excretion, and the urinary sodium-to-potassium ratio. Quantitative synthesis was not feasible because only a few included studies reported cardiovascular or adverse events. In conclusion, sodium reduction interventions effectively lower home BP, including morning home BP, with a greater impact in hypertensive populations. Thus, reducing sodium is a practical strategy for improving home BP control, particularly in hypertensive populations. This systematic review and meta-analysis of randomized controlled trials showed that sodium reduction interventions significantly lowered home systolic blood pressure (SBP), including morning SBP. No significant differences in BP-lowering effects were detected across various sodium reduction strategies, and digital health approaches may support implementation and adherence. Sodium reduction interventions were also associated with reductions in salt intake, urinary sodium excretion, and the urinary sodium-to-potassium ratio. These findings support major hypertension guidelines, including the Japanese Society of Hypertension Guidelines for managing elevated blood pressure and hypertension 2025 (JSH2025) and the JSH Morning Hypertension Eradication Program Project (Asakatsu BP Action Plan-the Morning Blood Pressure 130 Campaign).

Indexed as

Home blood pressureImplementation hypertensionMeta-analysisMorning blood pressureSodium reduction

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.